News
International conference: Paving the road to therapy
Hello everyone, From 17 till 19 March there will be an international conference about Lama2-MD in Barcelona. The conference LAMA2…
Research updates
-
![]()
News
-
![]()
News
Media coverage of the first clinical trials in Maastricht
This month, Maastricht UMC, led by Professor Bert Smeets, started a first clinical study in which healthy stem cells from…
-
![]()
Research updates
GYM Project – A New European Collaboration
The Generate Your Muscle (GYM) project was recently set up with the aim of developing and commercialising affordable stem cell…
-
![]()
Medical knowledge
Dr. Dwi Kemaladewi On A Promising New Therapeutic Strategy For LAMA2-CMD
Dr. Dwi Kemaladewi is playing a a key role in developing a novel therapeutic approach that has opened new treatment…
-
![]()
Medical knowledge
Prothelia: Developing A Protein Replacement Therapy For LAMA2-CMD
Steven Axon is the CEO of Prothelia, a biopharmaceutical company based in Massachusetts, USA, committed to developing a promising new…
-
![]()
Research updates
Prof. Bert Smeets On The Development Of Autologous Muscle Stem Cell Treatment
Professor Bert Smeets is involved in a number of investigations looking into a muscle stem cell treatment strategy to treat…
The driving forces behind Lama2.com
View all partners
